Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,081–2,088 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
IN8bio Inc. INB-400 Glioblastoma Multiforme(GBM) Phase 2 Enrollment Initiation intracerebral Oncology
IN8bio Inc. INB-100 Acute myeloid leukemia (AML) Phase 2 Data Released Intravenous Oncology
Incannex Healthcare Inc. IHL-675A Rheumatoid arthritis, inflammatory bowel disease and lung inflammation Phase 2 Enrollment Initiation oral Immunology: Anti-TNF
Incannex Healthcare Inc. PSX-001 (Psilocybin treatment) - (PsiGAD2) Generalized anxiety disorder (GAD) Phase 2 Ongoing Oral Psychiatric
Incannex Healthcare Inc. IHL-42X - (RePOSA) Obstructive sleep apnea (OSA) Phase 2/3 Data Released Oral Respiratory
Incyte Corporation Parsaclisib Follicular lymphoma NDA Filing Withdrawn Oral Oncology
Incyte Corporation Parsaclisib Marginal Zone Lymphoma NDA Filing Withdrawn Oral Oncology
Incyte Corporation Elraglusib Plus Retifanlimab 1L Advanced pancreatic cancer Phase 2 Trial Planned Intravenous Oncology